Vitamin D‐binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas
暂无分享,去创建一个
A. Uitterlinden | J. V. van Meurs | T. Nijsten | E. de Vries | S. Flohil | B. Stricker | Yue Fang | Sophie C. Flohil | A. Uitterlinden
[1] M. Chren,et al. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. , 2010, The Journal of investigative dermatology.
[2] B. Henderson,et al. Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[3] D. Gudbjartsson,et al. New common variants affecting susceptibility to basal cell carcinoma , 2009, Nature Genetics.
[4] A. Hofman,et al. Vitamin D Binding Protein Genotype and Osteoporosis , 2009, Calcified Tissue International.
[5] A. Testori,et al. Vitamin D and skin cancer: a meta-analysis. , 2009, European journal of cancer.
[6] J. Brisson,et al. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. , 2009, The American journal of clinical nutrition.
[7] Paolo Vineis,et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.
[8] W. Branicki,et al. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population , 2009, Experimental dermatology.
[9] D. Gudbjartsson,et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits , 2008, Nature Genetics.
[10] J. Chang-Claude,et al. The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] D. Trump,et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.
[12] K. Hemminki,et al. Case–control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre‐analysed in pooled DNA , 2006, The British journal of dermatology.
[13] G. Colditz,et al. Melanocortin 1 receptor variants and skin cancer risk , 2006, International journal of cancer.
[14] F. D. de Gruijl,et al. Predictions of skin cancer incidence in the Netherlands up to 2015 , 2005, The British journal of dermatology.
[15] J. Coebergh,et al. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. , 2004, Journal of Investigative Dermatology.
[16] Andrew G Smith,et al. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system. , 2003, Cancer letters.
[17] M. Pani,et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. , 2002, The Journal of clinical endocrinology and metabolism.
[18] P. Vestergaard,et al. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. , 2001, Clinical chemistry.
[19] J. Constans,et al. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP) , 1993, Human Genetics.
[20] Désirée Ratner,et al. Current concepts : Basal-cell carcinoma , 2005 .